Weed, INC

WEED Inc. reported a significant increase in net losses and a critical decline in cash, raising substantial doubt about its ability to continue as a going concern.

WEED, Inc. reported continued net losses and a significant decrease in cash for Q3 2025, raising substantial doubt about its ability to continue as a going concern.

WEED, Inc. reported no revenue and a significant increase in comprehensive loss for the first half of 2025, raising substantial doubt about its ability to continue as a going concern.

WEED, Inc. reports increased net losses for the quarter ended March 31, 2025, as the company continues to seek additional funding for its various cannabis and hemp-related business ventures.

WEED, Inc. reported a net loss for the third quarter of 2024, continuing its trend of operating without revenue while focusing on future opportunities in the cannabis and hemp industries.

WEED, Inc. reported a net loss of $110,953 for the second quarter of 2024, continuing its trend of operating without revenue while focusing on future opportunities in the cannabis and hemp industries.

WEED, Inc. filed its 2025 10-K, detailing a year focused on asset preservation, strategic technology exploration, and continued development of its cannabis genomic study, while facing significant going concern risks.

WEED, Inc.'s 10-K filing reveals ongoing efforts in cannabis research and development, underscored by persistent financial constraints and a need for additional funding.

WEED Inc.'s 10-K filing details its ongoing cannabis research and development efforts, including a genomic study and plans for infused beverages, while acknowledging significant financial hurdles.

Director and Officer Nicole Breen reported the sale of 111,058 shares of Weed, Inc. common stock across three transactions in May 2026.

WEED, Inc. Director and Officer Nicole M. Breen reported the sale of 240,605 shares of common stock across multiple transactions in early 2026.